ByHeart concludes largest U.S. clinical trial for infant food product

By Nikita Chaurasia  Date: 2021-06-03

ByHeart concludes largest U.S. clinical trial for infant food product

ByHeart Inc., a New-York based infant, and baby nutrition company, has recently announced the completion of the largest clinical trial for new infant formula in the past 25 years. With this move, the company is earmarked to be the 4th FDA registered, fully integrated infant formula company in the country.

The organization’s clinical study meets FDA's stringent requirements for infant formula and studies the impact of nutrition on babies’ holistic health and development as an extension of the trial. the trial results are expected to be released in the upcoming months, cited knowledgeable sources.

Co-founder of ByHeart, Ron Belldegrun, was quoted saying that nutrition science has evolved to acknowledge the significance of good fats in early development, and the company’s product is expected to be the first U.S-made formula produced with grass-fed, organic whole milk from farms that adhere to regenerative practices. 

He also added that every ingredient of the formula is hand-picked as the company not only aims to increase sales volumes but to upgrade the standard of infant formula recipes.

It is worth noting that ByHeart is the first of its kind, in decades to establish its manufacturing facility as opposed to choosing a contract manufacturer who would overlook the process from start to finish.

The co-founders Ron Belldegrun and Mia Funt reportedly chose to forego the traditional route and acquired and remodeled a manufacturing unit in Pennsylvania, to facilitate complete in-house R&D activities, direct sourcing, and to ensure total supervision over preventative safety measures.

Through complete control over ingredients and processes, the company can evolve its formulas more quickly and effectively to meet babies' nutritional requirements.

ByHeart is expected to launch the infant formula exclusively on its website by the end of the year, cited credible sources.

Source Link –

https://www.prnewswire.com/news-releases/byheart-completes-largest-us-clinical-trial-for-a-new-infant-formula-brand-in-the-last-25-years-supporting-their-innovation-in-baby-nutrition-301303254.html

 

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Netflix confirms producing fictionalized version of Spotify’s ascension

Netflix confirms producing fictionalized version of Spotify’s ascension

By Nikita Chaurasia

Over-the-top content streaming & production giant Netflix Inc. is reportedly working on an untitled series that tells the story of one of the most successful music streaming companies, Spotify Ltd. The six-part series, already listed on Netflix,...

Edtech Byju’s is now India’s highest-valued startup at USD 16.5 billion

Edtech Byju’s is now India’s highest-valued startup at USD 16.5 billion

By Nikita Chaurasia

Byju’s, the largest education technology company, has emerged as India’s highest-valued startup after a USD 340 million funding round involving investors such as UBS Group, Blackstone, and Zoom founder Eric Yuan among others. Recently, B...

LiDAR maker Hesai Photonics secures USD 300 million in Series D funding

LiDAR maker Hesai Photonics secures USD 300 million in Series D funding

By Nikita Chaurasia

Hesai Photonics Technology Co. Ltd., a leading Shanghai-based LiDAR company, has reportedly secured USD 300 million in a Series D funding round which was led by GL Ventures LLC, Xiaomi Corporation, Hillhouse Capital Group, Meituan, and CPE. The roun...

Tesla terminates production of its Model S Plaid + variant indefinitely

Tesla terminates production of its Model S Plaid + variant indefinitely

By Nikita Chaurasia

CEO Elon Musk justified Model S Plaid as good enough against its successor. The Model S Plaid + was touted to be Tesla’s flagship vehicle, with a range of around 519 miles. After unveiling for the first time last year, American EV maker T...

Uber witnesses a decrease in wait times as drivers return to work

Uber witnesses a decrease in wait times as drivers return to work

By Nikita Chaurasia

Ride costs increased by 40% in April amid driver shortage. Hourly driver earnings surged by 85% with some U.S. drivers earning more than USD 40 per hour. American ridesharing technology company Uber Technologies Inc. has recently announced that ...